Rituximab
Medication
AHFS/Drugs.com: Monograph
Bioavailability: 100% (IV)
DrugBank: DB00073
Elimination half-life: 30 to 400 hours (varies by dose and length of treatment)
Excretion: Uncertain: may undergo phagocytosis and catabolism in RES
License data: US DailyMed: Rituximab
MedlinePlus: a607038